 |
 |
 |
Search Stock:
Nectar Lifesciences Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Nectar Lifesciences (NECLIFE) Key Ratios
P/E
Company-0.75
Sector7.14
A Price-to-Earnings of -0.75 means investors pay -0.75 units per 1 unit of earnings. This is lower than the sector average of 7.14.
P/B
Company0.38
Sector4.34
A P/B ratio of 0.38 shows market value relative to book value. This is lower than the sector average of 4.34.
ROA
Company-47.12%
Sector-20.24%
Return on Assets shows a -47.12% profit per unit of asset. This is higher than the sector average of -20.24%.
ROE
Company-9.85%
Sector-3.31%
Return on Equity creates -9.85% profit per unit of equity. This is higher than the sector average of -3.31%.
ROCE
Company-8.75%
Sector6.3%
ROCE indicates -8.75% operating earnings per unit of capital. This is higher than the sector average of 6.3%.
EV/EBITDA
Company-0.38
Sector15.64
EV/EBITDA of -0.38 means value is -0.38 times core earnings. This is lower than the sector average of 15.64.
Nectar Lifesciences Share Price Analysis Local DB
Nectar Lifesciences share price is ₹12.35, day high (share price) is ₹12.58, day low (share price) is ₹11.66 and volume is 306,974. 52 Week high share price for Nectar Lifesciences is ₹22.40 on 23 Dec 2025 and 52 week low share price for Nectar Lifesciences is ₹9.30 on 30 Mar 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Nectar Lifesciences share, 14 day period RSI (Relative Strength Index) is 61.3, 50 DMA (50 Displaced Moving Average) is 11.09 and 200 DMA (200 Displaced Moving Average) is 13.33.
▲
₹12.35
0.22 (1.81%)
As of 02 Sep, 2026
Open
₹12.13
Day High - Low
₹12.58 - ₹11.66
Volume
306,974
52 Weeks High
₹22.40
on 23 Dec 2025
52 Weeks Low
₹9.30
on 30 Mar 2026
RSI (14)
61.3
50 DMA
11.09
200 DMA
13.33
Loading...
Nectar Lifesciences (NECLIFE) Technical Analysis
₹12.35
+0.22
02 Sep, 2026
Nectar Lifesciences Technical Data and Analysis available in multiple timeframes.
Nectar Lifesciences Oscillators Analysis
On the Day timeframe, the outlook for NECLIFE is: The long-term trend is Negative (Price vs 200 SMA) and RSI (14) is: 61.3.
Nectar Lifesciences Price Action
Nectar Lifesciences Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 61.26 |
| Stoch %K (14, 3, 3) | 66.38 |
| CCI (20) | 82.74 |
| ADX (14) | 23.29 |
| Awesome Osc | 1.66 |
| Momentum (10) | 1.83 |
| MACD (12, 26, 9) | 0.42 |
| MACD Signal | 0.25 |
| Stoch RSI (14) | 63.57 |
| Williams %R (14) | -33.33 |
| Bull/Bear Power | 0.66 |
| Ultimate Osc | 53.81 |
| MFI (14) | 61.22 |
| ROC (21) | 17.28 |
| ROC (125) | 1.23 |
| ATR (14) | 0.64 |
Nectar Lifesciences Moving Averages
NECLIFE is trading above 12 out of 14 SMAs.
12.35
CURRENT PRICE
Bullish Moving Averages
12
Bearish Moving Averages
2
5 SMA12.51
8 SMA12.14
9 SMA11.95
10 SMA11.78
12 SMA11.59
20 SMA11.28
21 SMA11.25
26 SMA11.09
30 SMA10.99
34 SMA10.96
50 SMA11.09
100 SMA11.66
150 SMA11.79
200 SMA13.33
| Ichimoku Base | 11.74 | Above Base |
| VWMA (20) | 11.80 | Above VWMA |
| HMA (9) | 12.64 | Below HMA |
Nectar Lifesciences Technical SWOT Analysis
STRENGTHS
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- MACD is above the signal line and in positive territory, reflecting supportive momentum.
- RSI at 61.26 indicates relatively strong momentum without being overbought.
WEAKNESSES
- Price is trading below the 200 DMA, indicating relatively weaker long-term structure.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Nectar Lifesciences Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 13.19 | 13.09 | 12.31 | 12.96 |
| Resistance 2 | 12.96 | 12.92 | 12.25 | 12.72 |
| Resistance 1 | 12.55 | 12.45 | 12.19 | 12.57 |
| Pivot Point | 12.32 | 12.28 | 12.13 | 12.32 |
| Support 1 | 11.91 | 11.81 | 12.07 | 12.08 |
| Support 2 | 11.68 | 11.64 | 12.01 | 11.93 |
| Support 3 | 11.27 | 11.17 | 11.95 | 11.68 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Nectar Lifesciences - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Jan 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 51.84% | 51.84% | 51.84% | 44.91% |
| FII | 0.50% | 0.60% | 0.58% | 0.52% |
| DII (Other) | 3.74% | 4.01% | 3.54% | 5.82% |
| Retail & Others | 43.91% | 43.54% | 44.03% | 48.75% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Nectar Lifesciences - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 9.29 +394.15% | -87.88 -8313.08% | -292.89 -157.64% |
| Mar 2025 | 1.88 -99.89% | 1.07 -94.14% | -113.68 -2378.16% |
| Mar 2024 | 1,698.66 +8.41% | 18.27 +143.07% | 4.99 +120.64% |
| Mar 2023 | 1,566.85 | -42.42 | -24.18 |
No corporate actions data available.
Nectar Lifesciences Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...